Caroline Baumal, Chief Medical Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 5,502 shares at $60.05 ($330K) on 2024-01-04, disclosed to the SEC on 2024-01-05.
Open-market sale of $330k APLS by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.05 | 2,751 | $165K | 50.0% |
| 2 | $60.05 | 2,751 | $165K | 50.0% |
| Total | $60.05 avg | 5,502 | $330K | 100% |
| Filing → |
| APLS | SELL | 2026-01-06 | $77K | — | Filing → |
| APLS | SELL | 2025-01-21 | $111K | — | Filing → |
| APLS | SELL | 2025-01-08 | $190K | — | Filing → |